Issues

Research Paper 82, November 2017

The International Debate on Generic Medicines of Biological Origin

The debate on generic medicines is not new. What makes it different today is that attacks levelled against biological products are couched in ever more “technical” and abstruse language that confuses even the World Health Organization (WHO).

(more…)

SC Side Event to COP23, 6 November 2017

Title:                What to expect from COP23

Date:                 Monday, 6  November 2017, 11h30-13h00

Venue:             Room 7 (Bonn Zone), Bonn, Germany

Organizers:    The South Centre, The Third World Network

(more…)

Research Paper 81, November 2017

Promoting Sustainable Development by Addressing the Impacts of Climate Change Response Measures on Developing Countries

Response measures arise in the context of developed and developing countries taking actions to combat climate change at global, national and regional levels, such as for the protection and stabilization of the climate, emissions leakages and/or the costs of environmental compliance. They may have unintended and adverse economic and social consequences for developing countries’ economies, most often on the poorest and most vulnerable sectors of those economies.

(more…)

SC Book Launch, 10 November 2017

Title:               “Another Crisis in the Making?” Book Launch of Dr. Yilmaz Akyuz’s Playing with Fire,

                          Deepened Financial Integration and Changing Vulnerabilities of the Global South

Date:                Friday, 10  November 2017, 13h00-15h00

Venue:             Room XXII, Palais des Nations, the United Nations Office in Geneva

Organizers:   The South Centre

(more…)

Research Paper 80, October 2017

The Commodity-Finance Nexus: Twin Boom and Double Whammy

International commodity prices and capital inflows to developing countries are increasingly synchronized, subjecting commodity-dependent economies to double boom-bust cycles.  (more…)

Informal Note on WTO MC11, November 2017

WTO MC11: Issues at Stake for Developing Countries

This is an informal briefing note on all the pertinent issues to developing countries for the 11th WTO Ministerial Conference which will be held in Buenos Aires in December 2017.

(more…)

Contribution to UNCTAD IGE FFD, November 2017

Input of the South Centre to the UNCTAD Intergovernmental Group of Experts on Financing for Development

This   is   a   contribution   by   the   South   Centre   to   the   first   session   of   the   UNCTAD Intergovernmental Group of Experts on Financing for Development (IGE-FFD) that will take place on 8-10 November 2017. (more…)

SouthViews No. 156, 26 October 2017

Intellectual Property for the TwentyFirst-Century Economy

By Joseph E. Stiglitz , Dean Baker , Arjun Jayadev

Developing countries are increasingly pushing back against the intellectual property regime foisted on them by the advanced economies over the last 30 years. They are right to do so, because what matters is not only the production of knowledge, but also that it is used in ways that put the health and wellbeing of people ahead of corporate profits. (more…)

SouthViews No. 155, 25 October 2017

The Trump tax reform plan is likely to negatively affect developing countries

By Yuefen LI

The Trump administration has proposed a tax reform framework to the US Congress. Major components are a large reduction in the corporate tax rate, changes to the way US profits currently earned abroad are taxed, and how past profits parked abroad are treated if brought home. All these reforms if accepted by Congress, will most likely have adverse effects for developing countries, including by increasing capital flows from and reducing FDI to them. (more…)

Policy Brief 45, October 2017

The Value Added of the United Nations General Assembly High–Level Political Declaration on Antimicrobial Resistance

In September 2016, the United Nations General Assembly (UNGA) in New York held a dedicated meeting to muster strong political commitment for an effective global response to the problem of antimicrobial resistance (AMR). As a result, a High-Level Political Declaration on Antimicrobial Resistance was adopted.

(more…)